Related Experiment Video
Updated: Dec 27, 2025

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
Adipose-derived mesenchymal stem cells-derived exosome-mediated microRNA-342-5p protects endothelial cells against
Xiaohui Xing1,2, Zhongchen Li2,3, Xin Yang4
1Department of Neurosurgery, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan 250000, Shandong Province, P.R. China.
Abstract:
Exosomes are reported to mediate several disease-related microRNAs (miRNAs) to affect the progression of diseases, including atherosclerosis. Here, we aimed to screen the atherosclerosis-associated miRNAs and preliminarily investigate the potential regulatory mechanism of atherosclerosis. First, the lesion model for human umbilical vein endothelial cells (HUVECs) was favorably constructed. Later, through RNA-sequencing and bioinformatics analyses, miR-342-5p was identified in lesion model for HUVECs. MiR-342-5p overexpression or knockdown evidently promoted or inhibited the apoptosis of HUVECs impaired by H2O2. Mechanistically, PPP1R12B was found to have great potential as a target of miR-342-5p in HUVECs impaired by H2O2, supported by RNA-sequencing and a series of bioinformatics analyses. Meanwhile, the effect of miR-342-5p on PPP1R12B expression in HUVECs' lesion model was explored, revealing that miR-342-5p had an inhibitory role in PPP1R12B expression. Additionally, adipose-derived mesenchymal stem cells (ADSCs) in spindle-like shape and their derived exosomes with 30 to 150 nm diameter were characterized. Furthermore, results showed miR-342-5p was evidently decreased in the presence of ADSCs-derived exosomes. These findings indicated ADSCs-derived exosomes restrained the expression of miR-324-5p in lesion model. Collectively, this work demonstrates an atherosclerosis-associated miR-342-5p and reveals a preliminary possible mechanism in which miR-342-5p mediated by ADSCs-derived exosomes protects endothelial cells against atherosclerosis.
Insights
Adipose-derived mesenchymal stem cell exosomes reduce miR-342-5p levels, protecting against atherosclerosis by inhibiting endothelial cell apoptosis. This study identifies a novel therapeutic pathway for atherosclerosis treatment.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Exosomes mediate microRNAs (miRNAs) influencing disease progression, including atherosclerosis.
- Understanding miRNA roles in atherosclerosis is crucial for developing targeted therapies.
- Human umbilical vein endothelial cells (HUVECs) are key players in vascular health and disease.
Purpose of the Study:
- To screen for atherosclerosis-associated miRNAs.
- To investigate the regulatory mechanism of atherosclerosis involving identified miRNAs.
- To explore the protective role of adipose-derived mesenchymal stem cell (ADSC)-derived exosomes.
Main Methods:
- Construction of a HUVEC lesion model.
- RNA-sequencing and bioinformatics analyses to identify miRNAs.
- Overexpression and knockdown experiments for miR-342-5p.
- Characterization of ADSC-derived exosomes.
- Assessment of exosome effects on miR-342-5p expression in HUVECs.
Main Results:
- miR-342-5p was identified as an atherosclerosis-associated miRNA in HUVECs.
- miR-342-5p modulated HUVEC apoptosis; its target was identified as PPP1R12B.
- ADSC-derived exosomes decreased miR-342-5p expression in the HUVEC lesion model.
Conclusions:
- miR-342-5p plays a significant role in endothelial cell apoptosis and atherosclerosis.
- ADSC-derived exosomes exert protective effects by downregulating miR-342-5p.
- This study reveals a potential therapeutic mechanism involving exosome-mediated miRNA regulation in atherosclerosis.
More Related Videos
Related Concept Videos
Mesenchymal Stem Cells
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

